Mersana Therapeutics, Inc.
NASDAQ:MRSN
2.19 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 174.561 | 280.712 | 177.947 | 255.094 | 62.351 | 59.634 | 26.591 | 100.297 | 11.534 |
| Short Term Investments
| 34.523 | 151.827 | 0 | 0 | 37.439 | 10.497 | 88.143 | 0 | 0 |
| Cash and Short Term Investments
| 209.084 | 280.712 | 177.947 | 255.094 | 99.79 | 70.131 | 114.734 | 100.297 | 11.534 |
| Net Receivables
| 0 | 30 | 0 | 0 | 0 | 0.459 | 0.784 | 1.051 | 0.64 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | -4.174 | 0 | 0 | 0 |
| Other Current Assets
| 4.973 | 8.507 | 10.951 | 3.486 | 1.536 | 3.715 | 2.025 | 0.825 | 0.58 |
| Total Current Assets
| 214.057 | 319.219 | 188.898 | 258.58 | 101.326 | 70.131 | 117.543 | 102.173 | 12.754 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 11.525 | 14.46 | 14.857 | 12.666 | 4.762 | 2.694 | 2.319 | 2.483 | 1.284 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0.478 | 0.478 | 0.478 | 0 | 0.321 | 0.371 | 10.482 | 0.321 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0 | 0.183 | 1.878 | 2.153 | 1.132 | 5.306 | 0.371 | 0.11 | 0.371 |
| Total Non-Current Assets
| 12.003 | 15.121 | 17.213 | 14.819 | 6.215 | 8.371 | 13.172 | 2.914 | 1.655 |
| Total Assets
| 226.06 | 334.34 | 206.111 | 273.399 | 107.541 | 78.502 | 130.715 | 105.087 | 14.409 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 7.319 | 13.951 | 12.321 | 8.34 | 7.296 | 10.727 | 3.07 | 2.068 | 2.025 |
| Short Term Debt
| 5.479 | 2.798 | 2.303 | 1.437 | 2.886 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 28.147 | 30.61 | 3.944 | 3.987 | 4.815 | 46.196 | 21.635 | 22.731 | 7.054 |
| Other Current Liabilities
| 22.692 | 44.174 | 28.955 | 16.239 | 9.073 | 12.502 | 7.176 | 3.587 | 1.656 |
| Total Current Liabilities
| 63.637 | 91.533 | 47.523 | 30.003 | 24.07 | 69.425 | 31.881 | 28.386 | 10.735 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 23.148 | 33.504 | 35.873 | 15.135 | 4.878 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 97.167 | 117.043 | 0 | 0 | 0 | 0 | 28.773 | 37.571 | 10.07 |
| Deferred Tax Liabilities Non-Current
| 5.203 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.001 | 0.203 | 0.974 | 0.174 | 0.275 | 0.282 | 0.067 | 94.749 | 36.296 |
| Total Non-Current Liabilities
| 125.519 | 150.75 | 36.847 | 15.309 | 5.153 | 0.282 | 28.84 | 132.32 | 46.366 |
| Total Liabilities
| 189.156 | 242.283 | 84.37 | 45.312 | 29.223 | 69.707 | 60.721 | 160.706 | 57.101 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 130.715 | 94.45 | 36.296 |
| Common Stock
| 0.012 | 0.011 | 0.007 | 0.007 | 0.005 | 0.003 | 0.003 | 0.001 | 0.001 |
| Retained Earnings
| -826.361 | -654.691 | -450.479 | -280.419 | -192.374 | -164.166 | -97.878 | -59.171 | -45.471 |
| Accumulated Other Comprehensive Income/Loss
| 0.011 | -0.152 | 0 | -0 | 0.025 | -0.008 | -0.149 | -4.212 | -3.557 |
| Other Total Stockholders Equity
| 863.242 | 746.889 | 572.213 | 508.499 | 270.662 | 172.966 | 37.303 | -86.687 | -29.961 |
| Total Shareholders Equity
| 36.904 | 92.057 | 121.741 | 228.087 | 78.318 | 8.795 | 69.994 | -55.619 | -42.692 |
| Total Equity
| 36.904 | 92.057 | 121.741 | 228.087 | 78.318 | 8.795 | 69.994 | -55.619 | -42.692 |
| Total Liabilities & Shareholders Equity
| 226.06 | 334.34 | 206.111 | 273.399 | 107.541 | 78.502 | 130.715 | 105.087 | 14.409 |